OppenheimerFunds’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-73,501
Closed -$4.73M 1919
2018
Q3
$4.73M Buy
73,501
+40,388
+122% +$2.46M 0.01% 790
2018
Q2
$1.62M Sell
33,113
-3,801
-10% -$197K ﹤0.01% 950
2018
Q1
$1.74M Sell
36,914
-185
-0.5% -$8.9K ﹤0.01% 906
2017
Q4
$1.85M Buy
37,099
+7,203
+24% +$358K ﹤0.01% 962
2017
Q3
$1.73M Buy
29,896
+3,250
+12% +$193K ﹤0.01% 981
2017
Q2
$1.79M Buy
26,646
+963
+4% +$60.9K ﹤0.01% 964
2017
Q1
$1.68M Buy
25,683
+3,459
+16% +$214K ﹤0.01% 997
2016
Q4
$1.26M Buy
22,224
+6,286
+39% +$364K ﹤0.01% 1034
2016
Q3
$944K Buy
15,938
+3,774
+31% +$226K ﹤0.01% 1035
2016
Q2
$795K Buy
12,164
+945
+8% +$64.2K ﹤0.01% 1065
2016
Q1
$777K Sell
11,219
-836
-7% -$55.8K ﹤0.01% 1080
2015
Q4
$885K Sell
12,055
-293,444
-96% -$20.9M ﹤0.01% 1081
2015
Q3
$21.7M Buy
305,499
+24,762
+9% +$2.01M 0.03% 515
2015
Q2
$24.4M Sell
280,737
-19,660
-7% -$1.49M 0.03% 532
2015
Q1
$22.1M Sell
300,397
-185,990
-38% -$13.2M 0.02% 564
2014
Q4
$35M Sell
486,387
-168,530
-26% -$11.7M 0.04% 450
2014
Q3
$45.3M Buy
654,917
+313,683
+92% +$22.1M 0.05% 362
2014
Q2
$21.2M Buy
+341,234
New +$20M 0.02% 565

Other funds holding LPNT

OppenheimerFunds's LPNT Position: Q4 2018 in Review

OppenheimerFunds sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 73,501 shares — an estimated $4.73M sold.

OppenheimerFunds first reported a position in LPNT in Q2 2014 and held it in 18 quarters. The position peaked at $45.3M in Q3 2014. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • OppenheimerFunds reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • OppenheimerFunds sold 73,501 LifePoint Health, Inc. shares in Q4 2018, an estimated $4.73M.
  • OppenheimerFunds first reported a position in LifePoint Health, Inc. in Q2 2014 and held it in 18 quarters.
  • OppenheimerFunds's LifePoint Health, Inc. position peaked at $45.3M in Q3 2014.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.